When the Analytic Third Includes a Psychodelic with Karen Peoples, PhD, Harvey Schwartz, Phd & Chris Stauffer, MD
The revival of scientific research into psychedelics over the past decade — often referred to as the “Psychedelic Renaissance” — shows promising therapeutic potential for difficult-to-treat conditions such as PTSD and substance use disorders. This program will track the rocky history of the use of psychedelics in Western society from early promising clinical research, through the 1960’s cultural explosion and the “war on drugs,” to their present use in FDA-approved clinical trials, and, lastly, in recent legislation such as Oregon’s Measure 109, the Psilocybin Services Act.
